Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.

Authors:
Shoaibi A; Lloyd PC; Wong HL; Clarke TC; Chillarige Y and 17 more

Journal:
Vaccine

Publication Year: 2023

DOI:
10.1016/j.vaccine.2023.06.014

PMCID:
PMC10266501

PMID:
37344261

Journal Information

Full Title: Vaccine

Abbreviation: Vaccine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 data availability the data that has been used is confidential."

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"AcknowledgementsFunding was provided by the US Food and Drug Administration.We would like to thank Purva Shah, Amei Hao, Yeerae Kim, and Mahasweta Mitra for providing statistical programming and writing support. We would like to thank Kristin Sepúlveda for program management."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025